Recent advances and current challenges in allogeneic stem cell transplantation in patients with acquired severe aplastic anemia

Allogeneic stem cell transplantation (SCT) from a human leukocyte antigen (HLA)-matched sibling donor (MSD-SCT) is the preferred first-line treatment option for young patients with severe aplastic anemia (SAA). However, only 25% of patients may find an HLA-MSD. SAA patients, who lack a suitable MSD...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sung-Eun, Lee, Jong Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651331/
http://dx.doi.org/10.31547/bct-2018-001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651331/
http://dx.doi.org/10.31547/bct-2018-001

Ejemplares similares